TFRC and pancreatic ductal adenocarcinoma: Chlorogenic acid inhibits the growth of pancreatic ductal adenocarcinoma cells by targeting the c-Myc-TFR1 axis, perhaps chlorogenic acid is a promising compound for pancreatic ductal adenocarcinoma therapy (64).